164 related articles for article (PubMed ID: 23864195)
1. Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells.
Zhong J; Yang L; Liu N; Zheng J; Lin CY
Dig Dis Sci; 2013 Nov; 58(11):3189-97. PubMed ID: 23864195
[TBL] [Abstract][Full Text] [Related]
2. Nuclear ING2 expression is reduced in osteosarcoma.
Han XR; Bai XZ; Sun Y; Yang Y
Oncol Rep; 2014 Nov; 32(5):1967-72. PubMed ID: 25190103
[TBL] [Abstract][Full Text] [Related]
3. miR‑92a contributes to cell proliferation, apoptosis and doxorubicin chemosensitivity in gastric carcinoma cells.
Tao XC; Zhang XY; Sun SB; Wu DQ
Oncol Rep; 2019 Jul; 42(1):313-320. PubMed ID: 31180538
[TBL] [Abstract][Full Text] [Related]
4. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.
Kumamoto K; Fujita K; Kurotani R; Saito M; Unoki M; Hagiwara N; Shiga H; Bowman ED; Yanaihara N; Okamura S; Nagashima M; Miyamoto K; Takenoshita S; Yokota J; Harris CC
Int J Cancer; 2009 Sep; 125(6):1306-15. PubMed ID: 19437536
[TBL] [Abstract][Full Text] [Related]
5. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
6. ING1 and ING2: multifaceted tumor suppressor genes.
Guérillon C; Larrieu D; Pedeux R
Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
[TBL] [Abstract][Full Text] [Related]
8. MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.
Sun G; Jin S; Baskaran R
Exp Cell Res; 2009 Nov; 315(18):3163-75. PubMed ID: 19766113
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
[TBL] [Abstract][Full Text] [Related]
10. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
[TBL] [Abstract][Full Text] [Related]
11. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
12. ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells.
Sarker KP; Kataoka H; Chan A; Netherton SJ; Pot I; Huynh MA; Feng X; Bonni A; Riabowol K; Bonni S
J Biol Chem; 2008 May; 283(19):13269-79. PubMed ID: 18334480
[TBL] [Abstract][Full Text] [Related]
13. ING2 controls the G1 to S-phase transition by regulating p21 expression.
Larrieu D; Ythier D; Brambilla C; Pedeux R
Cell Cycle; 2010 Oct; 9(19):3984-90. PubMed ID: 20890119
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
[TBL] [Abstract][Full Text] [Related]
15. A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis.
Unoki M; Kumamoto K; Robles AI; Shen JC; Zheng ZM; Harris CC
FEBS Lett; 2008 Nov; 582(28):3868-74. PubMed ID: 18951897
[TBL] [Abstract][Full Text] [Related]
16. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
17. ING2 controls the progression of DNA replication forks to maintain genome stability.
Larrieu D; Ythier D; Binet R; Brambilla C; Brambilla E; Sengupta S; Pedeux R
EMBO Rep; 2009 Oct; 10(10):1168-74. PubMed ID: 19730436
[TBL] [Abstract][Full Text] [Related]
18. ING2, a tumor associated gene, enhances PAI‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal.
Ohkouchi C; Kumamoto K; Saito M; Ishigame T; Suzuki SI; Takenoshita S; Harris CC
Mol Med Rep; 2017 Nov; 16(5):7367-7374. PubMed ID: 28944862
[TBL] [Abstract][Full Text] [Related]
19. Modulation of thyroid hormone-dependent gene expression in Xenopus laevis by INhibitor of Growth (ING) proteins.
Helbing CC; Wagner MJ; Pettem K; Johnston J; Heimeier RA; Veldhoen N; Jirik FR; Shi YB; Browder LW
PLoS One; 2011; 6(12):e28658. PubMed ID: 22163049
[TBL] [Abstract][Full Text] [Related]
20. ING proteins as potential anticancer drug targets.
Unoki M; Kumamoto K; Harris CC
Curr Drug Targets; 2009 May; 10(5):442-54. PubMed ID: 19442116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
